About this trial
This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.
Eligibility criteria
Qualifiers
The PE-CGS Research Center is only recruiting and sequencing tumors for adult-onset cancers (patients and survivors) among the American Indian Tribes, Nations, and Pueblos of New Mexico and adjacent states
Male or female adults (18 years) or older
Cancer patient undergoing active treatment or a cancer survivor
Self-identify as American Indian
Disqualifiers
Cognitively impaired
Adults unable to consent for themselves
Individuals who are not yet adults
Prisoners
Trial design
Treatments tested in this trial
- Biospecimen Collection
- Return of Results
- Survey Administration
Treatment groups
Sponsors and collaborators
New Mexico Cancer Research Alliance
Lead sponsor
National Cancer Institute (NCI)
Collaborator